Global Mesalazine Market Insights, Forecast to 2025

Mesalazine, also known as mesalamine or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
In 2018, the global Mesalazine market is lead by Europe. India is the second-largest region-wise market.
As for the consumption, Europe is the largest consumer, who owned 43.76% share in global consumption market in 2018, consumption volume was 1240.5 MT. The follower is India, with the consumption volume of 519.0 K MT in 2018, accounting for 18.31% sales share in 2018.

Syntese A/S was the largest manufacturer in 2018, with a market share of 23%. Other top 5 manufacturers were Divis Laboratories, Cambrex Corporation, Ipca Laboratories and PharmaZell, with total market share of 52%.
The global Mesalazine market is valued at 125 million US$ in 2018 and will reach 172 million US$ by the end of 2025, growing at a CAGR of 0.042 during 2019-2025. The objectives of this study are to define, segment, and project the size of the Mesalazine market based on company, product type, end user and key regions.

This report studies the global market size of Mesalazine in key regions like North America, Europe, China and India, focuses on the consumption of Mesalazine in these regions.
This research report categorizes the global Mesalazine market by top players/brands, region, type and end user. This report also studies the global Mesalazine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Syntese A/S
Divis Laboratories
Cambrex Corporation
Ipca Laboratories
Lasa Loboratory
Erregierre SpA
Corden Pharma Bergamo
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical

Mesalazine market size by Type
Purity ≥ 97 %
Purity ≥ 98 %
Purity ≥ 99 %

Purity≥98% occupied the largest sales share of 60.32% in 2018, consumption volume was 1346.6 MT. Purity≥99% growth fastest in the forecast period with a CAGR of 4.46% from 2019 to 2025.

Mesalazine market size by Applications
Mesalazine Tablets
Mesalazine Capsules

In 2018, the consumption volume of Mesalazine Tablets was 1456.0 MT, accounting for 51.36% of global share. And it excepted to reach 1811.9 MT in 2025, with the CAGR of 3.41% from 2019 to 2025, slightly lower than global market growth.

Market size by Region
North America
United States
South Korea
Central & South America
Middle East & Africa
GCC Countries
South Africa

The study objectives of this report are:

To study and analyze the global Mesalazine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Mesalazine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Mesalazine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Mesalazine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Mesalazine are as follows:
History Year: 2014-2018

Base Year:


Estimated Year:

Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Mesalazine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

  • By product type
  • By End User/Applications
  • By Technology
  • By Region

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.

Please Select a Format

market Reports market Reports